MTOR and metabolic dysfunction-associated steatotic liver disease: Importantly, SQLE upregulation is involved in OS-induced DNA methyltransferase 3A (DNMT3A) expression, DNMT3A-mediated epigenetic silencing of PTEN, and Akt–mTOR activation, which together triggers NAFLD.